Matches in SemOpenAlex for { <https://semopenalex.org/work/W98091970> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W98091970 endingPage "8" @default.
- W98091970 startingPage "315" @default.
- W98091970 abstract "The in vitro activities of cefoxitin, ampicillin/sulbactam, and imipenem were determined by the standard twofold agar dilution method against 62 strains of Escherichia coli and 40 strains of Klebsiella pneumoniae isolated from patients in intensive care units. Judging from the concentrations required to inhibit at least 90% of the test isolates, imipenem (MIC90 less than or equal to 0.125 micrograms/ml) was markedly more active than cefoxitin (MIC90 = 4 micrograms/ml) and ampicillin/sulbactam (MIC90 = 32 micrograms/ml) against both bacterial genera. Cefoxitin, therefore, was more active than ampicillin/sulbactam against these organisms. Breakpoints specified in the prescribing information are less than or equal to 4 micrograms/ml for imipenem, less than or equal to 16 micrograms/ml for cefoxitin, and less than or equal to 8 micrograms/ml for ampicillin/sulbactam. At these breakpoints all organisms were susceptible to imipenem and cefoxitin, while 73% of E coli and 78% of K pneumoniae were susceptible to ampicillin/sulbactam. At recommended susceptible MIC breakpoints of the National Committee for Clinical Laboratory Standards (less than or equal to 4 micrograms/ml for imipenem, less than or equal to 8 micrograms/ml for cefoxitin, and less than or equal to 4 micrograms/ml for ampicillin/sulbactam) all the isolates tested were susceptible to imipenem, while 98% and 73% of the E coli isolates were susceptible to cefoxitin and ampicillin/sulbactam, respectively, and 100% and 78% of the K pneumoniae isolates were susceptible to cefoxitin and ampicillin/sulbactam, respectively. Approximately 14% of E coli and 17% of K pneumoniae isolates were resistant to ampicillin/sulbactam (MIC greater than or equal to 32/16 micrograms/ml)." @default.
- W98091970 created "2016-06-24" @default.
- W98091970 creator A5047975768 @default.
- W98091970 creator A5086288352 @default.
- W98091970 creator A5090180043 @default.
- W98091970 date "1989-05-01" @default.
- W98091970 modified "2023-10-14" @default.
- W98091970 title "Comparative activity of cefoxitin, ampicillin/sulbactam, and imipenem against clinical isolates of Escherichia coli and Klebsiella pneumoniae." @default.
- W98091970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2663161" @default.
- W98091970 hasPublicationYear "1989" @default.
- W98091970 type Work @default.
- W98091970 sameAs 98091970 @default.
- W98091970 citedByCount "0" @default.
- W98091970 crossrefType "journal-article" @default.
- W98091970 hasAuthorship W98091970A5047975768 @default.
- W98091970 hasAuthorship W98091970A5086288352 @default.
- W98091970 hasAuthorship W98091970A5090180043 @default.
- W98091970 hasConcept C104317684 @default.
- W98091970 hasConcept C176947019 @default.
- W98091970 hasConcept C2776021129 @default.
- W98091970 hasConcept C2776124114 @default.
- W98091970 hasConcept C2777058267 @default.
- W98091970 hasConcept C2778478555 @default.
- W98091970 hasConcept C2779489039 @default.
- W98091970 hasConcept C2779631663 @default.
- W98091970 hasConcept C2780493024 @default.
- W98091970 hasConcept C501593827 @default.
- W98091970 hasConcept C523546767 @default.
- W98091970 hasConcept C54355233 @default.
- W98091970 hasConcept C547475151 @default.
- W98091970 hasConcept C55493867 @default.
- W98091970 hasConcept C71924100 @default.
- W98091970 hasConcept C86803240 @default.
- W98091970 hasConcept C89423630 @default.
- W98091970 hasConcept C94665300 @default.
- W98091970 hasConceptScore W98091970C104317684 @default.
- W98091970 hasConceptScore W98091970C176947019 @default.
- W98091970 hasConceptScore W98091970C2776021129 @default.
- W98091970 hasConceptScore W98091970C2776124114 @default.
- W98091970 hasConceptScore W98091970C2777058267 @default.
- W98091970 hasConceptScore W98091970C2778478555 @default.
- W98091970 hasConceptScore W98091970C2779489039 @default.
- W98091970 hasConceptScore W98091970C2779631663 @default.
- W98091970 hasConceptScore W98091970C2780493024 @default.
- W98091970 hasConceptScore W98091970C501593827 @default.
- W98091970 hasConceptScore W98091970C523546767 @default.
- W98091970 hasConceptScore W98091970C54355233 @default.
- W98091970 hasConceptScore W98091970C547475151 @default.
- W98091970 hasConceptScore W98091970C55493867 @default.
- W98091970 hasConceptScore W98091970C71924100 @default.
- W98091970 hasConceptScore W98091970C86803240 @default.
- W98091970 hasConceptScore W98091970C89423630 @default.
- W98091970 hasConceptScore W98091970C94665300 @default.
- W98091970 hasIssue "3" @default.
- W98091970 hasLocation W980919701 @default.
- W98091970 hasOpenAccess W98091970 @default.
- W98091970 hasPrimaryLocation W980919701 @default.
- W98091970 hasRelatedWork W1980746273 @default.
- W98091970 hasRelatedWork W2014685587 @default.
- W98091970 hasRelatedWork W2052571380 @default.
- W98091970 hasRelatedWork W2070753557 @default.
- W98091970 hasRelatedWork W2347283549 @default.
- W98091970 hasRelatedWork W2359415552 @default.
- W98091970 hasRelatedWork W2398868142 @default.
- W98091970 hasRelatedWork W2409026467 @default.
- W98091970 hasRelatedWork W3032649013 @default.
- W98091970 hasRelatedWork W98091970 @default.
- W98091970 hasVolume "11" @default.
- W98091970 isParatext "false" @default.
- W98091970 isRetracted "false" @default.
- W98091970 magId "98091970" @default.
- W98091970 workType "article" @default.